The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Long-term evolution of cardiomyopathy in dialysis patients
Open accessAbstract
Background Left ventricular enlargement is very common at the inception of dialysis therapy, and highly predictive of future cardiac morbidity and mortality. It is not known whether cardiac size increases further while on dialysis therapy and whether potentially reversible risk factors for later progression can be identified. METHODS; Baseline and yearly echocardiograms were performed in a prospective inception cohort of 433 dialysis patients. The mean patient follow-up was 41 months; 29 patients had four consecutive echocardiograms at yearly intervals.Results The patient subset with four echocardiograms was older (58 vs. 51 years, P = 0.02) and had a lower mass ventricular mass index (128 vs. 149 g/m2, P = 0.02) than the parent group. Using repeated measures analysis of variance, applied to those with four echocardiograms, there were progressive increases over time in posterior wall thickness (P = 0.015), left ventricular end-diastolic diameter, left ventricular mass index (P = 0.001), and cavity volume index (P = 0. 001). Mass-to-volume ratios did not change. The biggest changes in mass (18 g/m2 - 14%)and volume index (13 ml/m2 - 18%) occurred between baseline and year 1, although increases in both were seen after year 1. Hemodialysis versus peritoneal dialysis (41 g/m2, P = 0.008) and anemia (10 g/m2 per 1 g/dl drop in hemoglobin, P = 0.02) were associated with progressive left ventricular enlargement, but only within the first year of dialysis therapy. The left ventricular enlargement seen after year 1 was independent of anemia, blood pressure, serum albumin and mode of dialysis.Conclusions Progressive cardiac enlargement, particularly left ventricular dilation with compensatory hypertrophy, continues after starting dialysis therapy. Most of the additional cardiac enlargement seems to occur in the first year of dialysis therapy, suggesting that intervention beyond one year may be relatively ineffective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased risk of CAD also accompanies CKD, often with calcification of atherosclerotic plaques.679,689”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [689]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,226
Canadian Institute for Health Information.
Lalonde, A. (1994) · PubMed · Cited by 4,730
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Martin, C. J., Murray, D. C., & Barré, P. E. (1995) · Kidney International · doi:10.1038/ki.1995.22 · Cited by 1,294
Self-citationImpact of left ventricular hypertrophy on survival in end-stage renal disease
Silberberg, J. S., Barré, P. E., Prichard, S. S., & Sniderman, A. D. (1989) · Kidney International · doi:10.1038/ki.1989.192 · Cited by 780
The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barré, P. E. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90130-4 · Cited by 766
Self-citationCongestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors
Harnett, J. D., Foley, R. N., Kent, G. M., Barré, P. E., Murray, D. L., & Parfrey, P. S. (1995) · Kidney International · doi:10.1038/ki.1995.132 · Cited by 722
Self-citationLevin, A., Singer, J., Thompson, C. R., Ross, H., & Lewis, M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90357-1 · Cited by 709
Left Ventricular Volumes and Ejection Fraction by Echocardiography
Pombo, J., Troy, B. L., & Russell, R. O. (1971) · Circulation · doi:10.1161/01.cir.43.4.480 · Cited by 649
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barré, P. E. (1996) · Kidney International · doi:10.1038/ki.1996.194 · Cited by 490
Self-citationThe prognostic importance of left ventricular geometry in uremic cardiomyopathy.
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barré, P. E. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v5122024 · Cited by 480
Self-citation
Cited by
Sorted by citations
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Culleton, B., Walsh, M., Klarenbach, S., Mortis, G., Scott-Douglas, N., Quinn, R., Tonelli, M., Donnelly, S., Friedrich, M., Kumar, A., et al. (2007) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.298.11.1291 · Cited by 708
The Clinical Epidemiology of Cardiac Disease in Chronic Renal Failure
Parfrey, P. S., & Foley, R. N. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1071606 · Cited by 652
Self-citationTraditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease
Muntner, P., He, J., Astor, B. C., Folsom, A. R., & Coresh, J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080656 · Cited by 490
Metadata
- Authors
- Foley, R. N., Parfrey, P. S., Kent, G. M., Harnett, J. D., Murray, D. C., & Barre, P. E.
- Affiliations
- Memorial University of Newfoundland (CA)
- Corresponding author
- Foley, Robert N.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 1998-11
- Volume
- 54
- Issue
- 5
- Pages
- 1720-1725
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2130476101
- Cited by
- 226
- References
- 39
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 9 · 2015: 15 · 2014: 2 · 2013: 3 · 2012: 13
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Memorial University of Newfoundland
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- left ventricular hypertrophy, left ventricular dilatation, dialysis patients, hemodialysis, peritoneal dialysis, anemia, left ventricular mass index, left ventricular end-diastolic diameter, cardiac remodeling, echocardiography
- MeSH terms
- Blood Pressure, Echocardiography, Renal Dialysis, Humans, Middle Aged, Prospective Studies, Hypertrophy, Left Ventricular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
